Diabetic retinopathy (DR) is a complication of diabetes and one of the leading causes of
vision loss worldwide. Despite extensive efforts to reduce visual impairment, the prevalence …

Diabetes mellitus is a major cause of avoidable blindness in both the developing and the
developed countries. Significant technological advances have taken place to improve the …

Importance Vitreous hemorrhage from proliferative diabetic retinopathy can cause loss of
vision. The best management approach is unknown. Objective To compare initial treatment …

In 1970, Robert Machemer performed the first pars plana vitrectomy (PPV) on a patient with
a nonclearing diabetic vitreous hemorrhage (NCVH) of 5-year duration, achieving an …

Surgery for late complications of proliferative diabetic retinopathy remains the cornerstone of
management even in patients who have received optimal laser photocoagulation and …

Over the past four decades, advancements in surgical instrumentations and techniques
have significantly improved the postoperative anatomical and visual outcomes of patients …

Despite recent advances in the medical management of diabetic retinal disease, there
remain established indications for vitreoretinal surgery in the treatment of severe …

Purpose To evaluate costs and cost-utility of early vitrectomy (pars plana vitrectomy [PPV])
compared with panretinal photocoagulation (PRP) and intravitreal ranibizumab (IVR) for …

The management of antiplatelet and anticoagulant treatment can be challenging for the
ophthalmic surgeon with the risk of impaired surgical view or potentially sight-threatening …

Despite the existence of treatment for diabetes, inadequate metabolic control triggers the
appearance of chronic complications such as diabetic retinopathy. Diabetic retinopathy is …